We are live on ! Find out more
RCMNY

Rubric Capital Management (New York) Portfolio holdings

AUM $9.44B
1-Year Est. Return 68.42%
This Fund
S&P 500
This Quarter Est. Return
+1.19%
1 Year Est. Return
+68.42%
3 Year Est. Return
+212.09%
5 Year Est. Return
+270.59%
10 Year Est. Return
AUM
$1.99B
AUM Growth
+$81.5M
Cap. Flow
+$144M
Cap. Flow %
7.26%
Top 10 Hldgs %
40.54%
Holding
101
New
13
Increased
27
Reduced
12
Closed
14

Top Buys

Rank Stock Value
1
MATV icon
Mativ Holdings
MATV
+$56.2M
2
NE icon
Noble Corp
NE
+$42.9M
3
DEN
Denbury Inc.
DEN
+$42.8M
4
GPRE icon
Green Plains
GPRE
+$34.6M
5
DOLE icon
Dole
DOLE
+$28.9M

Sector Composition

Rank Sector Weight
1 Healthcare 23.08%
2 Industrials 19.95%
3 Energy 18.9%
4 Financials 10.05%
5 Materials 8.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CLBT icon
76
Cellebrite
CLBT
$3.8B
$2.47M 0.12%
629,020
MRNS
77
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$2.1M 0.11%
315,277
SIOX
78
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$1.96M 0.1%
7,000,000
+988,995
+16% +$339K
QSI icon
79
Quantum-Si Incorporated
QSI
$182M
$1.85M 0.09%
672,385
SCTL
80
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
$1.75M 0.09%
1,076,587
NAUT icon
81
Nautilus Biotechnolgy
NAUT
$114M
$1.58M 0.08%
747,607
KORE
82
DELISTED
KORE Group Holdings
KORE
$1.36M 0.07%
142,450
RNAC icon
83
Cartesian Therapeutics
RNAC
$263M
$1.18M 0.06%
24,042
PASG icon
84
Passage Bio
PASG
$14.8M
$1.03M 0.05%
41,105
LOTZ
85
DELISTED
CarLotz, Inc. Class A Common Stock
LOTZ
$853K 0.04%
2,842,302
-157,698
-5% -$68.9K
LYLT
86
DELISTED
Loyalty Ventures Inc. Common Stock
LYLT
$603K 0.03%
498,504
VIAO
87
DELISTED
VIA optronics AG American Depositary Shares, each representing one-fifth of an Ordinary Share
VIAO
$403K 0.02%
251,855
BTAI icon
88
BioXcel Therapeutics
BTAI
$32.7M
-24,478
Closed -$5.17M
CMPS
89
Compass Pathways
CMPS
$1.97B
-283,694
Closed -$3.07M
GEF icon
90
Greif
GEF
$5B
-600,000
Closed -$37.4M
BRSL
91
Brightstar Lottery PLC
BRSL
$2.08B
-1,287,163
Closed -$23.9M
INSM icon
92
Insmed
INSM
$28.9B
-1,288,276
Closed -$25.4M
ITOS
93
DELISTED
iTeos Therapeutics
ITOS
-822,112
Closed -$16.9M
IVVD icon
94
Invivyd
IVVD
$216M
-1,812,347
Closed -$5.94M
RGNX icon
95
Regenxbio
RGNX
$720M
-287,467
Closed -$7.1M
SWIR
96
DELISTED
Sierra Wireless
SWIR
-295,683
Closed -$6.92M
AERI
97
DELISTED
Aerie Pharmaceuticals
AERI
-1,231,483
Closed -$9.24M
PING
98
DELISTED
Ping Identity Holding Corp.
PING
-473,709
Closed -$8.59M
IEA
99
DELISTED
Infrastructure and Energy Alternatives, Inc. Common Stock
IEA
-2,810,831
Closed -$22.6M
RDUS
100
DELISTED
Radius Health, Inc.
RDUS
-6,959,305
Closed -$72.2M

Similar funds

Rubric Capital Management (New York)'s Q3 2022 Portfolio in Review

As of Q3 2022, Rubric Capital Management (New York) held 101 positions worth $1.99B, up 4.3% from $1.9B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Rubric Capital Management (New York) deployed $144M of net new capital in Q3 2022, opening 13 new positions and adding to 27 existing holdings. Its largest new stake was Mativ Holdings: 2,456,759 shares worth $54.2M.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 23% a quarter earlier, followed by Industrials and Energy.

On the sell side, the largest reduction was Hertz, an estimated $13.8M trimmed.

  • Rubric Capital Management (New York)'s largest Q3 2022 buy was Mativ Holdings: 2,456,759 shares worth $54.2M.
  • Rubric Capital Management (New York) added most to Mr. Cooper in Q3 2022, an estimated $19.1M increase.
  • Rubric Capital Management (New York)'s biggest Q3 2022 reduction was Hertz, cutting an estimated $13.8M.
  • Rubric Capital Management (New York) fully exited Radius Health, Inc. in Q3 2022, selling an estimated $72.2M.
  • Rubric Capital Management (New York)'s ten largest holdings make up 41% of its $1.99B portfolio in Q3 2022.
  • Rubric Capital Management (New York) opened 13 new positions and closed 14 in Q3 2022.
  • Rubric Capital Management (New York)'s portfolio value rose 4.3% quarter-over-quarter to $1.99B.

Based on Rubric Capital Management (New York)'s 13F filing for Q3 2022, filed 14 Nov 2022.